Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Glioblastoma 49Breast Neoplasms 49Prostatic Neoplasms 47Carcinoma, Non-Small-Cell Lung 47Squamous Cell Carcinoma of Head and Neck 37Lung Neoplasms 29Head and Neck Neoplasms 26Glioma 22Rectal Neoplasms 21Sarcoma 20Neoplasms 20Brain Neoplasms 20Oropharyngeal Neoplasms 16Esophageal Neoplasms 15Uterine Cervical Neoplasms 14Neoplasm Metastasis 14Astrocytoma 13Triple Negative Breast Neoplasms 12Esophageal Squamous Cell Carcinoma 12Carcinoma, Hepatocellular 12Pancreatic Neoplasms 11Melanoma 11Gliosarcoma 10Colorectal Neoplasms 10Stomach Neoplasms 9Small Cell Lung Carcinoma 9Lymphoma 9Hodgkin Disease 9Carcinoma, Squamous Cell 9Urinary Bladder Neoplasms 8

Interventions

Paclitaxel 7Cyclophosphamide 6Doxorubicin 5pembrolizumab 3Trastuzumab 3Taxes 3Specimen Handling 3Carboplatin 3pertuzumab 2eribulin 2Radiotherapy 2Epirubicin 2Docetaxel 2trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1ruxolitinib 1pegfilgrastim 1onvansertib 1olaparib 1neratinib 1durvalumab 1cobimetinib 1atezolizumab 1X-Rays 1Therapeutics 1Tamoxifen 1Surgical Procedures, Operative 1Radiation 1Peripheral Blood Stem Cell Transplantation 1Panitumumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Inflammatory Breast Neoplasms × Radiotherapy × 1 year × Clear all
NCT03598257 2026-05-13

Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
300 enrolled
Breast

Inflammatory Breast Neoplasms

NCT05415215 2026-02-10

ProHer

Hoffmann-La Roche

Phase 3 Completed
346 enrolled 20 charts
Breast

Breast Neoplasms, Patient Preference, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡